Table 1.
A comparative synthesis of acute and environmental stressors, associated gut microbiome alterations, and functional implications. It integrates evidence across physiological, occupational and extreme environments to highlight cross-domain resilience mechanisms and translational opportunities.
| Stressor category | Representative context | Microbiome alterations (comparative synthesis) | Functional and metabolic implications | Potential resilience or mitigation strategies |
|---|---|---|---|---|
| Circadian disruption and sleep loss | Human and rodent models of jetlag or sleep restriction | Reduced microbial diversity and beneficial taxa (Lactobacillaceae); altered Firmicutes/Bacteroidetes ratio; disrupted rhythmicity of bacterial metabolism | Perturbation of short-chain fatty acid (SCFA) and bile acid pathways; mitochondrial and metabolic dysregulation | Restoration of SCFA-producing taxa through prebiotic or timed feeding interventions improves circadian alignment and host resilience |
| Psychological and physical stress | Military and occupational training, high workload | Loss of beneficial genera such as Bifidobacterium and enrichment of proinflammatory taxa | HPA axis overactivation, reduced microbial metabolites linked to stress buffering | Synbiotic formulations combining Lactobacillus acidophilus, Bifidobacterium animalis and inulin improved physiological and cognitive outcomes |
| Thermal and environmental stress | Heat acclimation and cold exposure in animal and human studies | Selective expansion of probiotic species (Lactobacillus, Bifidobacterium); reduction of opportunistic pathogens | Enhanced thermotolerance and immune stability under temperature variation | Thermal acclimation and nutritional support promote microbiome-mediated adaptation |
| Hypobaric hypoxia (high altitude) | Mountaineering and hypoxia chamber exposure | Increase in proinflammatory bacteria; depletion of anaerobic commensals | Inflammation, oxidative stress and impaired gastrointestinal integrity | Glutamine and antioxidant supplementation support microbial balance and barrier function |
| Infectious stressors (travelers’ diarrhea) | Enterotoxigenic Escherichia coli, Shigella and Campylobacter exposure | Transient dysbiosis, reduction of protective taxa and overgrowth of pathogens | Gut barrier disruption, systemic inflammation and reduced nutrient absorption | Galacto-oligosaccharide supplementation and probiotic therapy shown to reduce diarrhea incidence and restore microbiota |
| Spaceflight and microgravity | Astronauts (International Space Station, MARS500) and hindlimb unloading models | Reduced microbial diversity, altered abundance of Parasutterella and Akkermansia, increased Firmicutes | Dysregulated immunity and glucose metabolism, enhanced oxidative stress | Probiotic supplementation and crocodile gut-derived bacterial metabolites shown to mitigate dysbiosis in simulated microgravity |
| Hardy species and adaptive microbiomes | Crocodylus and Varanus species | Presence of stress-tolerant microbes and producers of bioactive metabolites such as leucrocin, cathelicidin and hepcidin | Potential for antimicrobial, anti-inflammatory and epigenetic modulation via secondary metabolites | Isolation and characterization of microbial metabolites for translational probiotic applications |
| Dietary and nutritional modulation | High-fat or low-fiber diets, malnutrition | Reduced SCFA-producing taxa and overall microbial diversity | Disturbed nutrient metabolism, immune dysregulation and inflammation | Fiber-rich and prebiotic diets restore microbial homeostasis and support physiological resilience |